Generation of Lipid Nanoparticle mRNA Vaccines and Evaluation of Antigen-Specific CD8+ T-Cell Responses
摘要
mRNA vaccines have revolutionized vaccine development against infectious diseases, as demonstrated by the rapid creation and deployment of vaccines for SARS-CoV-2. In this chapter, we present a protocol for the generation of mRNA vaccine formulations utilizing lipid nanoparticle-based delivery systems. Additionally, we provide guidance for the evaluation of (i) mRNA formulation immunogenicity, (ii) mRNA formulation induced antigen cross-presentation, and (iii) antigen-specific CD8+ T-cell responses post in vivo vaccination.